01235 832023
Monica specialises in Aquatic exercise and disability active gym at The Park Club. She is affected by the neurological disease ALD/AMN and is aware of some of the challenges people face when going to the gym. Please click here for further information monica instructability leafet
There are also Disability Active leaflets available at the centre.
I have some Radar Keys if anyone would like to purchase, they are £5 each.
We have been nominated in the Didcot Community and Business Awards, thank you very much to those who nominated us, lets 
see what happens.
Source Multiple Sclerosis News Today: Physical exercise fights fatigue and depression in patients with multiple sclerosis (MS), a 
new study reveals.
Remarkably, these positive outcomes in psychological health can be achieved without significant alterations in the patient’s body weight or body mass index (BMI), further supporting the idea that exercise could be an effective therapeutic intervention for MS.
The study with these findings, “Effect of Short-Term Interval Exercise Training on Fatigue, Depression, and Fitness in Normal Weight vs. Overweight Person With Multiple Sclerosis,” was published in EXPLORE: The Journal of Science and Healing.
MS patients usually are advised to maintain a healthy diet, as diet and body weight can interfere with their energy levels, body functions, and disease progression. Read on.
Source BBC: The over-65s vaccine will protect against three strains of flu, but people under 65, in the so-called at-risk groups, 
will be offered a vaccine that protects against four types of flu. At-risk groups include pregnant women and those with long-term health conditions.
The enhanced vaccine that will be given this year contains extra ingredients designed to help aged immune systems develop a stronger defence against flu.
It is hoped the “adjuvanted vaccine” will help ease pressures on the health service.
Public Health England estimates the vaccine will lead to:
Prof Paul Cosford, from Public Health England, told the BBC: “This looks like it is going to be is a significant improvement and quite a step in our battle against flu each winter.” Read on.
Source the Telegraph: “As doctors, we are left feeling powerless when we deliver the devastating diagnosis of PPMS to people 
because we know there is currently no disease-modifying treatment available to help them.
“It is even more frustrating that an effective treatment that can help slow the disease has been developed and made available across the globe yet people in England and Wales will continue to suffer disability worsening because of an archaic and inflexible medicine assessment system.”
Thousands of multiple sclerosis patients have been denied a drug which could delay them needing a wheelchair for seven years, even though the manufacturer has agreed to slash the price.
The National Institute for Health and Care Excellence (Nice) today announced that it will not be funding ocrelizumab for primary progressive MS available on the NHS in England and Wales. Read on.
Source UAB News: Results from a clinical trial of more than 250 participants with progressive multiple sclerosis revealed that ibudilast was better than a placebo in slowing down brain shrinkage.
The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, and was published in the New England Journal of Medicine.
Robert J. Fox, M.D., a neurologist at Cleveland Clinic in Ohio, led a team of researchers across 28 clinical sites, including a team from the University of Alabama at Birmingham, in a brain imaging study to investigate whether ibudilast was better than placebo in reducing the progression of brain atrophy, or shrinkage, in patients with progressive multiple sclerosis. Read on.
Source MS Society: Ocrelizumab should be available on the NHS for everyone with primary progressive MS who could benefit. 
We call on NHS England, the National Institute of Health and Care Excellence (NICE) and Roche to work together to secure a deal to make that happen.
Raise your voice and help the MS Society tell NICE and NHS England: give people with primary progressive MS access to ocrelizumab. Sign their petition
MS Annual Quiz Night, Friday 12th October, The Barn (Didcot Conservative Club), 7 for 7.30 start, £7 per person, up to 8 in a team. Please advertise to your friends, put on your facebook post etc.
Please please can members donate some raffle prizes, especially drink, chocolates, biscuits etc.
Many thanks,
Click here for full details poster
August 100 club winners: Barbara Bentley, Lindsay Brain, Linda Tierney.
Congratulations